Rocha V, Mooyaart JE, Ram R, Clesham K, Daskalakis M, Huynh A, Potter V, Chaganti S, Gabellier L, Tholouli E, Collin M, Nicholson E, Protheroe R, Passweg J, Ayuk F, Schneidawind D, Kwon M, Corral LL, Zeiser R, Scheid C, Yakoub-Agha I, Dreger P, Stolzel F, Hoogenboom J, Coelho MHM, Tomas AA, Malard F, Kuball J, Sureda A, Barzabachi A, Ruggeri A. Improved progression free survival after axicabtagene ciloleucel compared to tisagenlecleucel, in patients aged >70 years with large B-cell lymphoma. Haematologica; https://doi.org/10.3324/haematol.2026.300508 [Early view].